Global Infertility Market 2015-2019

Global Infertility Market 2015-2019

Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems.

Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019.

Read more details @

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Infertility market for the period 2015-2019. The Global Infertility market can be divided into two segments: Infertility Drugs and Infertility Devices. To calculate the market size, the report considers revenue generated from the sales of various drugs and devices used in the treatment of infertility.

Global Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Infertility market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas

Key Vendors
• Bayer Healthcare
• CooperSurgical
• Ferring Pharmaceuticals
• Merck & Co.

Other Prominent Vendors
• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Bristol-Myers Squibb
• Dong-A Socio
• Elelixis Diagnostics
• Eli Lily
• Halotech DNA
• HRA Pharma
• Invo Bioscience
• Medical Electronic...

Similar Essays